<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044479</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Ocular infiltration in a patient with multiple myeloma</dc:title>
<dc:description xml:lang="en">Case report: We report the case of a patient with Multiple Myeloma Ig G Kappa stage IIIA and hepatic infiltration, who presented with ocular infiltration. The initial sign was a rapidly growing sub-conjunctival mass that caused ophthalmoplegia and increased intraocular pressure secondary to progressive infiltration of the orbit. Discussion: Multiple Myeloma is a malignant tumor of plasma cells that can affect the eye and orbit, not only as an infiltration secondary to the disease but also primary as an isolated tissue proliferation (extramedullary plasmacytoma). Chemotherapy is the usual treatment given. Radiotherapy with or without excisional surgery is the first option for plasmacytomas</dc:description>
<dc:creator>García-Sánchez, J</dc:creator>
<dc:creator>Díaz-Valle, D</dc:creator>
<dc:creator>Saiz, M</dc:creator>
<dc:creator>Troyano, J</dc:creator>
<dc:creator>Benítez-del-Castillo, J. M</dc:creator>
<dc:creator>Santos-Bueso, E</dc:creator>
<dc:creator>Calvo-González, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Se describe un caso de infiltración ocular en un paciente con mieloma múltiple Ig G Kappa estadio IIIA con infiltración hepática. El cuadro clínico ocular debutó como masa subconjuntival de rápido crecimiento que produjo oftalmoplejia e incremento de la presión intraocular por infiltración progresiva orbitaria.Discusión: El mieloma múltiple es una neoplasia maligna de células plasmáticas que puede presentarse en el territorio ocular como infiltración secundaria al mieloma o como proliferación aislada (plasmocitoma extramedular). El tratamiento de elección es la quimioterapia y en los plasmocitomas la radioterapia local con o sin excisión quirúrgica</dc:description>
<dc:source>Arch Soc Esp Oftalmol;80(12): 725-728, dic. 2005. ilus</dc:source>
<dc:identifier>ibc-044479</dc:identifier>
<dc:title xml:lang="es">Infiltración ocular en paciente con mieloma múltiple</dc:title>
<dc:subject>^d8287^s22064</dc:subject>
<dc:subject>^d22589^s22064</dc:subject>
<dc:subject>^d22589^s22058</dc:subject>
<dc:subject>^d27726^s22027</dc:subject>
<dc:subject>^d8287^s22057</dc:subject>
<dc:subject>^d22589^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24375</dc:subject>
<dc:subject>^d28204^s22027</dc:subject>
<dc:subject>^d9293^s22057</dc:subject>
<dc:subject>^d9293^s22058</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d9293^s22064</dc:subject>
<dc:subject>^d974^s22073</dc:subject>
<dc:subject>^d7591</dc:subject>
<dc:type>article</dc:type>
<dc:date>200512</dc:date>
</metadata>
</record>
</ibecs-document>
